ACHV compared with IDXX: revenue, margins and what each company keeps, and the suppliers and customers both name

ACHVAchieve Life Sciences, Inc.

Mkt capRevenueRevenue

IDXXIdexx Laboratories Inc

Mkt capRevenueRevenue

Compare

ACHVAchieve Life Sciences, Inc.

IDXXIdexx Laboratories Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ACHV1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.9%▼−1.18%×0.11

IDXX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±8.6%▲+21.85%×2.55

Q2 FY26±8.4%▲+3.57%×0.43

= impliedACHV realized, solidIDXX realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±8.0%

▼−0.03%

×0.00

Feb 2 '26±8.9%▼−4.60%×0.52

ACHVAchieve Life Sciences, Inc.

6.71▲+5.33%· post 6.71

Mkt cap$691.5MRevenue—Revenue—

IDXXIdexx Laboratories Inc

676.84▲+0.91%· post 677.73

ClosedNov 6 '26

Mkt cap$53.3BRevenue$1.2BQ3 FY26Revenue$4.3BFY25

Compare

ClosedNov 6 '26

ACHVAchieve Life Sciences, Inc.

IDXXIdexx Laboratories Inc

6.71▲+5.33%post 6.71

Price

676.84▲+0.91%post 677.73

$691.5M

Mkt cap

$53.3B

—

Revenue

$1.2BQ3 FY26

—

Revenue

$4.3BFY25

ACHV6.71▲+5.33%vsIDXX676.84▲+0.91%ClosedNov 6 '26